. .

BioTime wins another $4M investment

BioTime wins another $4M investment

The leader of regenerative medicine BioTime, Inc. based in Alameda has received $4 million from Broadwood Partners LP and George Karfunkel in return for receiving common share and stock purchase. Previously the company raised $4 million from the same investors as well as a $4.7 million grant from California stem cell research funding agency. The money will be used to build company's product using embryonic stem cell technology.  

SF Business Times-7/13/2009